SPHERA FUNDS MANAGEMENT
Sphera Funds Management ("Sphera") is an Israeli-based fund manager established in 2004. Sphera and its affiliated entities are managing three separate hedge funds, Sphera Fund, Sphera Global Healthcare Fund, Sphera Small Cap Fund.
SPHERA FUNDS MANAGEMENT
Social Links:
Industry:
Angel Investment Health Care Venture Capital
Founded:
2004-01-01
Status:
Active
Contact:
+972036845535
Email Addresses:
[email protected]
Technology used in webpage:
Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Employees Featured
Israel Mor
Israel Mor Co-Founder, Managing Partner, Sphera Fund @ Sphera Funds Management Co-Founder, Managing Partner, Sphera Fund
Ido Birman
Ido Birman CMO @ Sphera Funds Management CMO
Neomi Elpelg
Neomi Elpelg CFO @ Sphera Funds Management CFO
Adi Hanetz
Adi Hanetz CCO @ Sphera Funds Management CCO
LIana Hartal Kaneti
LIana Hartal Kaneti COO @ Sphera Funds Management COO
Founder
Israel Mor
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2021-06-22 | Neurona Therapeutics | Sphera Funds Management investment in Venture Round - Neurona Therapeutics | 41.5 M USD |
2021-03-17 | Reunion Neuroscience | Sphera Funds Management investment in Post-IPO Equity - Reunion Neuroscience | 95 M CAD |
2020-09-25 | Galecto | Sphera Funds Management investment in Series D - Galecto | 64 M USD |
2020-09-14 | ESCAPE Bio | Sphera Funds Management investment in Venture Round - ESCAPE Bio | 73 M USD |
2020-07-02 | ElectReon | Sphera Funds Management investment in Post-IPO Equity - ElectReon | 50 M USD |
2020-06-16 | C4 Therapeutics | Sphera Funds Management investment in Series B - C4 Therapeutics | N/A |
2020-03-17 | immatics biotechnologies | Sphera Funds Management investment in Post-IPO Equity - immatics biotechnologies | 104 M USD |
2019-09-04 | Passage Bio | Sphera Funds Management investment in Series B - Passage Bio | 110 M USD |
2019-08-21 | Oncorus | Sphera Funds Management investment in Series B - Oncorus | 79.5 M USD |
2018-10-23 | Stoke Therapeutics | Sphera Funds Management investment in Series B - Stoke Therapeutics | 90 M USD |